An update on vitamin D and human immunity

Clinical Endocrinology

Volumn 76, Issue 3, 2012, Pages 315-325

  Hewison, Martin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL; ERGOCALCIFEROL DERIVATIVE; PLACEBO; VITAMIN D;

ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASE; CARDIOVASCULAR DISEASE; HOMEOSTASIS; HUMAN; HYPERTENSION; IMMUNOMODULATION; INNATE IMMUNITY; MINERAL METABOLISM; NEOPLASM; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; RICKETS; TUBERCULOSIS; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ADAPTIVE IMMUNITY; DENDRITIC CELLS; DIETARY SUPPLEMENTS; HUMANS; IMMUNITY, INNATE; MACROPHAGES; MODELS, IMMUNOLOGICAL; RECEPTORS, CALCITRIOL; T-LYMPHOCYTES; VITAMIN D;

EID: 84856999767     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04261.x     Document Type: Review

References (134)

1. Ross, A.C., Manson, J.E., Abrams, S.A., et al. (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. Journal of Clinical Endocrinology and Metabolism, 96, 53-58.
2. Haussler, M.R., Haussler, C.A., Bartik, L., et al. (2008) Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. Nutrition Reviews, 66, S98-S112.
3. Slomski, A., (2011) IOM endorses vitamin D, calcium only for bone health, dispels deficiency claims. JAMA, 305, 453-454.
4. Reid, I.R., &, Avenell, A., (2011) Evidence-based policy on dietary calcium and vitamin D. Journal of Bone and Mineral Research, 26, 452-454.
5. Heaney, R.P., &, Holick, M.F., (2011) Why the IOM recommendations for vitamin D are deficient. Journal of Bone and Mineral Research, 26, 455-457.
6. Grant, W.B., (2011) Is the Institute of Medicine report on calcium and vitamin D good science? Biological Research for Nursing, 13, 117-119.
7. Grant, W.B., (2011) The Institute of Medicine did not find the vitamin D-cancer link because it ignored UV-B dose studies. Public Health Nutrition, 14, 745-746.
8. Hollis, B.W., &, Wagner, C.L., (2011) The vitamin D requirement during human lactation: the facts and IOM's 'utter' failure. Public Health Nutrition, 14, 748-749.
9. Deeb, K.K., Trump, D.L., &, Johnson, C.S., (2007) Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nature Reviews Cancer, 7, 684-700. (Pubitemid 47327412)
10. Krishnan, A.V., &, Feldman, D., (2011) Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. Annual Review of Pharmacology and Toxicology, 51, 311-336.
11. Motiwala, S.R., &, Wang, T.J., (2011) Vitamin D and cardiovascular disease. Current Opinion in Nephrology and Hypertension, 20, 345-353.
12. Geleijnse, J.M., (2011) Vitamin D and the prevention of hypertension and cardiovascular diseases: a review of the current evidence. American Journal of Hypertension, 24, 253-262.
13. Harms, L.R., Burne, T.H., Eyles, D.W., et al. (2011) Vitamin D and the brain. Best Practice & Research Clinical Endocrinology Metabolism, 25, 657-669.
14. Chapuy, M.C., Preziosi, P., Maamer, M., et al. (1997) Prevalence of vitamin D insufficiency in an adult normal population. Osteoporosis International, 7, 439-443. (Pubitemid 27443069)
15. Heaney, R.P., Dowell, M.S., Hale, C.A., et al. (2003) Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. Journal of the American College of Nutrition, 22, 142-146. (Pubitemid 36417827)
16. Heaney, R.P., (2011) 25-Hydroxyvitamin D and calcium absorption. American Journal of Clinical Nutrition, 93, 220-221; author reply 221.
17. Holick, M.F., (2008) Vitamin D status: measurement, interpretation, and clinical application. Annals of Epidemiology, 19, 73-78.
18. Peacock, M., Selby, P.L., Francis, R.M., et al. (1985) Vitamin D deficiency insufficiency sufficiency and intoxication what do they mean. In: Vitamin D: Chemical, Biochemical and Clinical Update: Proceedings of the Sixth Workshop on Vitamin D., A.W. Norman, K. Schaefer, H.G. Grogoleit, D.V. Herrath, et al. eds. De Gruyter, Berlin, 569-570.
19. Aloia, J.F., Talwar, S.A., Pollack, S., et al. (2006) Optimal vitamin D status and serum parathyroid hormone concentrations in African American women. American Journal of Clinical Nutrition, 84, 602-609. (Pubitemid 44713411)
20. Steingrimsdottir, L., Gunnarsson, O., Indridason, O.S., et al. (2005) Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA, 294, 2336-2341. (Pubitemid 41607410)
21. Benjamin, A., Moriakova, A., Akhter, N., et al. (2009) Determinants of 25-hydroxyvitamin D levels in African-American and Caucasian male veterans. Osteoporosis International, 20, 1795-1803.
22. Stolzenberg-Solomon, R.Z., Jacobs, E.J., Arslan, A.A., et al. (2010) Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. American Journal of Epidemiology, 172, 81-93.
23. Holick, M.F., (2007) Vitamin D deficiency. New England Journal of Medicine, 357, 266-281.
24. Grad, R., (2004) Cod and the consumptive: a brief history of cod-liver oil in the treatment of pulmonary tuberculosis. Pharmacy in History, 46, 106-120.
25. Rook, G.A., Steele, J., Fraher, L., et al. (1986) Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology, 57, 159-163. (Pubitemid 16232232)
26. Koeffler, H.P., Reichel, H., Bishop, J.E., et al. (1985) gamma-Interferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophages. Biochemical and Biophysical Research Communications, 127, 596-603. (Pubitemid 16217468)
27. Takeda, K., &, Akira, S., (2005) Toll-like receptors in innate immunity. International Immunology, 17, 1-14.
28. Liu, P.T., Stenger, S., Li, H., et al. (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science, 311, 1770-1773.
29. Wang, T.T., Nestel, F.P., Bourdeau, V., et al. (2004) Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. Journal of Immunology, 173, 2909-2912. (Pubitemid 39141992)
30. Gombart, A.F., Borregaard, N., &, Koeffler, H.P., (2005) Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB Journal, 19, 1067-1077. (Pubitemid 40946432)
31. Adams, J.S., Ren, S., Liu, P.T., et al. (2009) Vitamin d-directed rheostatic regulation of monocyte antibacterial responses. Journal of Immunology, 182, 4289-4295.
32. Edfeldt, K., Liu, P.T., Chun, R., et al. (2010) T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proceedings of the National Academy of Sciences of the United States of America, 107, 22593-22598.
33. Krutzik, S.R., Hewison, M., Liu, P.T., et al. (2008) IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. Journal of Immunology, 181, 7115-7120.
34. Liu, P.T., Schenk, M., Walker, V.P., et al. (2009) Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS ONE, 4, e5810.
35. Brennan, A., Katz, D.R., Nunn, J.D., et al. (1987) Dendritic cells from human tissues express receptors for the immunoregulatory vitamin D3 metabolite, dihydroxycholecalciferol. Immunology, 61, 457-461. (Pubitemid 17127352)
36. Penna, G., &, Adorini, L., (2000) 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. Journal of Immunology, 164, 2405-2411. (Pubitemid 30115468)
37. Adorini, L., Penna, G., Giarratana, N., et al. (2003) Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases. Journal of Cellular Biochemistry, 88, 227-233. (Pubitemid 36119891)
38. Hewison, M., Freeman, L., Hughes, S.V., et al. (2003) Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. Journal of Immunology, 170, 5382-5390. (Pubitemid 36617823)
39. Griffin, M.D., Lutz, W., Phan, V.A., et al. (2001) Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America, 98, 6800-6805. (Pubitemid 32538297)
40. Panda, D.K., Miao, D., Tremblay, M.L., et al. (2001) Targeted ablation of the 25-hydroxyvitamin D 1alpha -hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proceedings of the National Academy of Sciences of the United States of America, 98, 7498-7503. (Pubitemid 32567977)
41. Enioutina, E.Y., Bareyan, D., &, Daynes, R.A., (2009) TLR-induced local metabolism of vitamin D3 plays an important role in the diversification of adaptive immune responses. Journal of Immunology, 182, 4296-4305.
42. Provvedini, D.M., Tsoukas, C.D., Deftos, L.J., et al. (1983) 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science, 221, 1181-1183.
43. Lemire, J.M., Adams, J.S., Sakai, R., et al. (1984) 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. Journal of Clinical Investigation, 74, 657-661. (Pubitemid 14054016)
44. Lemire, J.M., Adams, J.S., Kermani-Arab, V., et al. (1985) 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. Journal of Immunology, 134, 3032-3035. (Pubitemid 15249817)
45. Abbas, A.K., Murphy, K.M., &, Sher, A., (1996) Functional diversity of helper T lymphocytes. Nature, 383, 787-793. (Pubitemid 26372655)
46. Romagnani, S., (2006) Regulation of the T cell response. Clinical and Experimental Allergy, 36, 1357-1366. (Pubitemid 44674119)
47. Lemire, J.M., Archer, D.C., Beck, L., et al. (1995) Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. Journal of Nutrition, 125, 1704S-1708S.
48. Boonstra, A., Barrat, F.J., Crain, C., et al. (2001) 1alpha,25- Dihydroxyvitamin D3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. Journal of Immunology, 167, 4974-4980. (Pubitemid 33009728)
49. Penna, G., Amuchastegui, S., Cossetti, C., et al. (2006) Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin D receptor agonist elocalcitol. Journal of Immunology, 177, 8504-8511. (Pubitemid 44895295)
50. Tang, J., Zhou, R., Luger, D., et al. (2009) Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. Journal of Immunology, 182, 4624-4632.
51. Joshi, S., Pantalena, L.C., Liu, X.K., et al. (2011) 1,25- dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Molecular and Cellular Biology, 31, 3653-3669.
52. Barrat, F.J., Cua, D.J., Boonstra, A., et al. (2002) In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. Journal of Experimental Medicine, 195, 603-616. (Pubitemid 34461505)
53. Rudensky, A.Y., (2011) Regulatory T cells and Foxp3. Immunological Reviews, 241, 260-268.
54. Ardalan, M.R., Maljaei, H., Shoja, M.M., et al. (2007) Calcitriol started in the donor, expands the population of CD4+ CD25+ T cells in renal transplant recipients. Transplantation Proceedings, 39, 951-953. (Pubitemid 46764934)
55. Smolders, J., Thewissen, M., Peelen, E., et al. (2009) Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS ONE, 4, e6635.
56. Royal W. III, Mia, Y., Li, H., et al. (2009) Peripheral blood regulatory T cell measurements correlate with serum vitamin D levels in patients with multiple sclerosis. Journal of Neuroimmunology, 213, 135-141.
57. Penna, G., Amuchastegui, S., Giarratana, N., et al. (2007) 1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. Journal of Immunology, 178, 145-153. (Pubitemid 46033595)
58. Jeffery, L.E., Burke, F., Mura, M., et al. (2009) 1,25-Dihydroxyvitamin D(3) and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. Journal of Immunology, 183, 5458-5467.
59. Fritsche, J., Mondal, K., Ehrnsperger, A., et al. (2003) Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha,25-dihydroxyvitamin D3 by human dendritic cells. Blood, 102, 3314-3316. (Pubitemid 37314772)
60. Sigmundsdottir, H., Pan, J., Debes, G.F., et al. (2007) DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nature Immunology, 8, 285-293. (Pubitemid 46745378)
61. Chen, S., Sims, G.P., Chen, X.X., et al. (2007) Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. Journal of Immunology, 179, 1634-1647.
62. Heine, G., Niesner, U., Chang, H.D., et al. (2008) 1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells. European Journal of Immunology, 38, 2210-2218.
63. Shirakawa, A.K., Nagakubo, D., Hieshima, K., et al. (2008) 1,25-dihydroxyvitamin D3 induces CCR10 expression in terminally differentiating human B cells. Journal of Immunology, 180, 2786-2795.
64. Chocano-Bedoya, P., &, Ronnenberg, A.G., (2009) Vitamin D and tuberculosis. Nutrition Reviews, 67, 289-293.
65. Wilkinson, R.J., Llewelyn, M., Toossi, Z., et al. (2000) Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet, 355, 618-621. (Pubitemid 30099469)
66. Ustianowski, A., Shaffer, R., Collin, S., et al. (2005) Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London. Journal of Infection, 50, 432-437. (Pubitemid 40692029)
67. Williams, B., Williams, A.J., &, Anderson, S.T., (2008) Vitamin D deficiency and insufficiency in children with tuberculosis. Pediatric Infectious Disease Journal, 27, 941-942.
68. Wejse, C., Gomes, V.F., Rabna, P., et al. (2009) Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. American Journal of Respiratory and Critical Care Medicine, 179, 843-850.
69. Nnoaham, K.E., &, Clarke, A., (2008) Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. International Journal of Epidemiology, 37, 113-119. (Pubitemid 351228619)
70. Martineau, A.R., Honecker, F.U., Wilkinson, R.J., et al. (2007) Vitamin D in the treatment of pulmonary tuberculosis. Journal of Steroid Biochemistry and Molecular Biology, 103, 793-798. (Pubitemid 46401341)
71. Martineau, A.R., Wilkinson, R.J., Wilkinson, K.A., et al. (2007) A single dose of vitamin D enhances immunity to mycobacteria. American Journal of Respiratory and Critical Care Medicine, 176, 208-213. (Pubitemid 47057859)
72. Nursyam, E.W., Amin, Z., &, Rumende, C.M., (2006) The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Medica Indonesiana, 38, 3-5.
73. Martineau, A.R., Timms, P.M., Bothamley, G.H., et al. (2011) High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet, 377, 242-250.
74. Montoya, D., Cruz, D., Teles, R.M., et al. (2009) Divergence of macrophage phagocytic and antimicrobial programs in leprosy. Cell Host & Microbe, 6, 343-353.
75. Chaglassian, H.T., (1948) Calciferol treatment of leprosy; preliminary report of two cases. The Journal of Investigative Dermatology, 10, 303.
76. Herrera, G., (1949) Vitamin D in massive doses as an adjuvant to the sulfones in the treatment of tuberculoid leprosy. International Journal of Leprosy, 17, 35-42.
77. Moller, K.I., Kongshoj, B., Philipsen, P.A., et al. (2005) How Finsen's light cured lupus vulgaris. Photodermatology, Photoimmunology and Photomedicine, 21, 118-124. (Pubitemid 40775142)
78. Jeng, L., Yamshchikov, A.V., Judd, S.E., et al. (2009) Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. Journal of Translational Medicine, 7, 28.
79. Sorensen, O., Cowland, J.B., Askaa, J., et al. (1997) An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma. Journal of Immunological Methods, 206, 53-59. (Pubitemid 27395865)
80. Takahashi, K., Nakayama, Y., Horiuchi, H., et al. (2002) Human neutrophils express messenger RNA of vitamin D receptor and respond to 1alpha,25-dihydroxyvitamin D3. Immunopharmacology and Immunotoxicology, 24, 335-347.
81. Gombart, A.F., Bhan, I., Borregaard, N., et al. (2009) Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis. Clinical Infectious Diseases, 48, 418-424.
82. Cannell, J.J., Vieth, R., Umhau, J.C., et al. (2006) Epidemic influenza and vitamin D. Epidemiology and Infection, 134, 1129-1140. (Pubitemid 44614932)
83. Bergman, P., Walter-Jallow, L., Broliden, K., et al. (2007) The antimicrobial peptide LL-37 inhibits HIV-1 replication. Current HIV Research, 5, 410-415. (Pubitemid 47040482)
84. Schauber, J., Dorschner, R.A., Coda, A.B., et al. (2007) Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. Journal of Clinical Investigation, 117, 803-811. (Pubitemid 46348539)
85. Yim, S., Dhawan, P., Ragunath, C., et al. (2007) Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25- dihydroxyvitamin D(3). Journal of Cystic Fibrosis, 6, 403-410. (Pubitemid 350028703)
86. Evans, K.N., Nguyen, L., Chan, J., et al. (2006) Effects of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on cytokine production by human decidual cells. Biology of Reproduction, 75, 816-822. (Pubitemid 44845586)
87. Liu, N., Kaplan, A.T., Low, J., et al. (2009) Vitamin D induces innate antibacterial responses in human trophoblasts via an intracrine pathway. Biology of Reproduction, 80, 398-406.
88. Adorini, L., &, Penna, G., (2008) Control of autoimmune diseases by the vitamin D endocrine system. Nature Clinical Practice Rheumatology, 4, 404-412.
89. Littorin, B., Blom, P., Scholin, A., et al. (2006) Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia, 49, 2847-2852. (Pubitemid 44730286)
90. Harris, S.S., (2005) Vitamin D in type 1 diabetes prevention. Journal of Nutrition, 135, 323-325. (Pubitemid 40194500)
91. Beretich, B., &, Beretich, T., (2009) Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis. Multiple Sclerosis, 15, 891-898.
92. Munger, K.L., Levin, L.I., Hollis, B.W., et al. (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA, 296, 2832-2838. (Pubitemid 44969183)
93. Cantorna, M.T., Hayes, C.E., &, DeLuca, H.F., (1996) 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 93, 7861-7864. (Pubitemid 26277129)
94. Spach, K.M., Pedersen, L.B., Nashold, F.E., et al. (2004) Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis. Physiological Genomics, 18, 141-151. (Pubitemid 39319496)
95. Spach, K.M., &, Hayes, C.E., (2005) Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. Journal of Immunology, 175, 4119-4126. (Pubitemid 41292076)
96. Nashold, F.E., Spach, K.M., Spanier, J.A., et al. (2009) Estrogen controls vitamin D3-mediated resistance to experimental autoimmune encephalomyelitis by controlling vitamin D3 metabolism and receptor expression. Journal of Immunology, 183, 3672-3681.
97. Cantorna, M.T., (2006) Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease. Progress in Biophysics and Molecular Biology, 92, 60-64. (Pubitemid 43831951)
98. Kamen, D., &, Aranow, C., (2008) Vitamin D in systemic lupus erythematosus. Current Opinion in Rheumatology, 20, 532-537.
99. Goswami, R., Marwaha, R.K., Gupta, N., et al. (2009) Prevalence of vitamin D deficiency and its relationship with thyroid autoimmunity in Asian Indians: a community-based survey. British Journal of Nutrition, 102, 382-386.
100. Vogeser, M., (2010) Quantification of circulating 25-hydroxyvitamin D by liquid chromatography-tandem mass spectrometry. Journal of Steroid Biochemistry and Molecular Biology, 121, 565-573.
101. Carter, G.D., &, Jones, J.C., (2009) Use of a common standard improves the performance of liquid chromatography-tandem mass spectrometry methods for serum 25-hydroxyvitamin-D. Annals of Clinical Biochemistry, 46, 79-81.
102. Carter, G.D., Berry, J.L., Gunter, E., et al. (2010) Proficiency testing of 25-hydroxyvitamin D (25-OHD) assays. Journal of Steroid Biochemistry and Molecular Biology, 121, 176-179.
103. Uitterlinden, A.G., Fang, Y., Van Meurs, J.B., et al. (2004) Genetics and biology of vitamin D receptor polymorphisms. Gene, 338, 143-156. (Pubitemid 39094759)
104. Gao, L., Tao, Y., Zhang, L., et al. (2010) Vitamin D receptor genetic polymorphisms and tuberculosis: updated systematic review and meta-analysis. The International Journal of Tuberculosis and Lung Disease, 14, 15-23.
105. Zhang, H.Q., Deng, A., Guo, C.F., et al. (2010) Association between FokI polymorphism in vitamin D receptor gene and susceptibility to spinal tuberculosis in Chinese Han population. Archives of Medical Research, 41, 46-49.
106. Soborg, C., Andersen, A.B., Range, N., et al. (2007) Influence of candidate susceptibility genes on tuberculosis in a high endemic region. Molecular Immunology, 44, 2213-2220. (Pubitemid 46110907)
107. Lewis, S.J., Baker, I., &, Davey Smith, G., (2005) Meta-analysis of vitamin D receptor polymorphisms and pulmonary tuberculosis risk. The International Journal of Tuberculosis and Lung Disease, 9, 1174-1177. (Pubitemid 41433810)
108. Arai, H., Miyamoto, K., Taketani, Y., et al. (1997) A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. Journal of Bone and Mineral Research, 12, 915-921. (Pubitemid 27225001)
109. Ates, O., Dolek, B., Dalyan, L., et al. (2011) The association between BsmI variant of vitamin D receptor gene and susceptibility to tuberculosis. Molecular Biology Reports, 38, 2633-2636.
110. Ramos-Lopez, E., Jansen, T., Ivaskevicius, V., et al. (2006) Protection from type 1 diabetes by vitamin D receptor haplotypes. Annals of the New York Academy of Sciences, 1079, 327-334. (Pubitemid 44968742)
111. Smolders, J., Damoiseaux, J., Menheere, P., et al. (2009) Association study on two vitamin D receptor gene polymorphisms and vitamin D metabolites in multiple sclerosis. Annals of the New York Academy of Sciences, 1173, 515-520.
112. Tajouri, L., Ovcaric, M., Curtain, R., et al. (2005) Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population. Journal of Neurogenetics, 19, 25-38. (Pubitemid 41656874)
113. Ban, Y., Taniyama, M., &, Ban, Y., (2000) Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population. Journal of Clinical Endocrinology and Metabolism, 85, 4639-4643. (Pubitemid 32157646)
114. Lee, Y.H., Bae, S.C., Choi, S.J., et al. (2011) Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Molecular Biology Reports, 38, 3643-3651.
115. Abbasi, M., Rezaieyazdi, Z., Afshari, J.T., et al. (2010) Lack of association of vitamin D receptor gene BsmI polymorphisms in patients with systemic lupus erythematosus. Rheumatology International, 30, 1537-1539.
116. Bailey, R., Cooper, J.D., Zeitels, L., et al. (2007) Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes, 56, 2616-2621. (Pubitemid 47523270)
117. Jennings, C.E., Owen, C.J., Wilson, V., et al. (2005) A haplotype of the CYP27B1 promoter is associated with autoimmune Addison's disease but not with Graves' disease in a UK population. Journal of Molecular Endocrinology, 34, 859-863. (Pubitemid 40903607)
118. Sundqvist, E., Baarnhielm, M., Alfredsson, L., et al. (2010) Confirmation of association between multiple sclerosis and CYP27B1. European Journal of Human Genetics, 18, 1349-1352.
119. Arnaud, J., &, Constans, J., (1993) Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP). Human Genetics, 92, 183-188. (Pubitemid 23272286)
120. Chun, R.F., Lauridsen, A.L., Suon, L., et al. (2010) Vitamin D-binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin D. Journal of Clinical Endocrinology and Metabolism, 95, 3368-3376.
121. Powe, C.E., Ricciardi, C., Berg, A.H., et al. (2011) Vitamin D binding protein modifies the vitamin D-bone mineral density relationship. Journal of Bone and Mineral Research, 26, 1609-1616.
122. Martineau, A.R., Leandro, A.C., Anderson, S.T., et al. (2009) Association between Gc genotype and susceptibility to TB is dependent on vitamin D status. European Respiratory Journal, 35, 1106-1112.
123. Lauridsen, A.L., Vestergaard, P., &, Nexo, E., (2001) Mean serum concentration of vitamin D-binding protein (Gc globulin) is related to the Gc phenotype in women. Clinical Chemistry, 47, 753-756. (Pubitemid 32275824)
124. Lauridsen, A.L., Vestergaard, P., Hermann, A.P., et al. (2005) Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women. Calcified Tissue International, 77, 15-22. (Pubitemid 41504168)
125. Wang, T.J., Zhang, F., Richards, J.B., et al. (2010) Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet, 376, 180-188.
126. Yamamoto, N., &, Homma, S., (1991) Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes. Proceedings of the National Academy of Sciences of the United States of America, 88, 8539-8543. (Pubitemid 21915392)
127. Wood, A.M., Bassford, C., Webster, D., et al. (2011) Vitamin D-binding protein contributes to COPD by activation of alveolar macrophages. Thorax, 66, 205-210.
128. Nagpal, S., Na, S., &, Rathnachalam, R., (2005) Noncalcemic actions of vitamin D receptor ligands. Endocrine Reviews, 26, 662-687. (Pubitemid 41127276)
129. Westwood, S.A., Seaman, P.J., O'Brien, C., et al. (1987) The phenotypic frequencies of group specific component and alpha-2-HS-glycoprotein in three ethnic groups. The use of these proteins as racial markers in forensic biology. Forensic Science International, 35, 197-207. (Pubitemid 18002717)
130. Holick, M.F., Biancuzzo, R.M., Chen, T.C., et al. (2008) Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. Journal of Clinical Endocrinology and Metabolism, 93, 677-681. (Pubitemid 351398538)
131. Heaney, R.P., Recker, R.R., Grote, J., et al. (2011) Vitamin D(3) is more potent than vitamin D(2) in humans. Journal of Clinical Endocrinology and Metabolism, 96, E447-E452.
132. Romagnoli, E., Mascia, M.L., Cipriani, C., et al. (2008) Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. Journal of Clinical Endocrinology and Metabolism, 93, 3015-3020.
133. Glendenning, P., Chew, G.T., Seymour, H.M., et al. (2009) Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol. Bone, 45, 870-875.
134. Sochorova, K., Budinsky, V., Rozkova, D., et al. (2009) Paricalcitol (19-nor-1,25-dihydroxyvitamin D2) and calcitriol (1,25-dihydroxyvitamin D3) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells. Clinical Immunology, 133, 69-77.